Lentiviral-MGMT gene transfer into hematopoietic stem cells
LENTIGEN CORPORATION · Department of Health and Human Services
Phase I2010$2,652,660
DESCRIPTION (provided by applicant): Therapeutic stem cell gene transfer relies on long-term gene expression achieved by integration of new DNA into the cellular genome. Current clinical trials featuring oncoretroviruse…